CRISPR editing in pancreatic cells reduced cell death and increased insulin secretion
Thursday, December 1, 2016 - 10:01
in Health & Medicine
With the help of the CRISPR/Cas9 gene scissors, researchers at Lund University Diabetes Centre in Sweden have managed to "turn off" an enzyme that proved to play a key role in the regulation of the diabetes-associated TXNIP gene. The results are decreased cell death and increased insulin production in the genetically modified pancreatic beta cells.